Activation of nucleotide-binding oligomerization domain 2 by muramyl dipeptide negatively regulates Toll-like receptor 9-mediated colonic inflammation through the induction of deubiquitinating enzyme A expression

被引:18
作者
Masuta, Yasuhiro [1 ]
Minaga, Kosuke [1 ]
Kurimoto, Masayuki [1 ]
Sekai, Ikue [1 ]
Hara, Akane [1 ]
Omaru, Naoya [1 ]
Okai, Natsuki [1 ]
Otsuka, Yasuo [1 ]
Takada, Ryutaro [1 ]
Yoshikawa, Tomoe [1 ]
Masaki, Sho [1 ]
Kamata, Ken [1 ]
Honjo, Hajime [1 ]
Arai, Yasuyuki [2 ]
Yamashita, Kouhei [2 ]
Kudo, Masatoshi [1 ]
Watanabe, Tomohiro [1 ]
机构
[1] Kindai Univ, Dept Gastroenterol & Hepatol, Fac Med, 377-2 Ohno Higashi, Osaka 5898511, Japan
[2] Kyoto Univ, Dept Hematol & Oncol, Grad Sch Med, Kyoto 6068507, Japan
基金
日本学术振兴会;
关键词
colitis; DUBA; NOD2; TLR9; type I IFN; PROTECTS MICE; ULCERATIVE-COLITIS; DENDRITIC CELLS; CPG MOTIFS; NOD2; AUTOPHAGY; RESPONSES; TRAF3; DUBA;
D O I
10.1093/intimm/dxac045
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Mutations in nucleotide-binding oligomerization domain 2 (NOD2) are associated with Crohn's disease (CD). Although NOD2 activation contributes to the maintenance of intestinal homeostasis through the negative regulation of pro-inflammatory cytokine responses mediated by Toll-like receptors (TLRs), the effects of NOD2 activation on interferon (IFN)-alpha responses induced by TLR9 have been poorly defined. To explore the cross-talk between NOD2 and TLR9, human monocytes or dendritic cells (DCs) were stimulated with NOD2 and/or TLR9 ligands to measure IFN-alpha production. The severity of dextran sodium sulfate (DSS)-induced colitis was compared in mice treated with NOD2 and/or TLR9 ligands. Expression of IFN-alpha and IFN-stimulated genes (ISGs) was examined in the colonic mucosa of patients with inflammatory bowel disease (IBD). NOD2 activation reduced TLR9-induced IFN-alpha production by monocytes and DCs in a deubiquitinating enzyme A (DUBA)-dependent manner. Activation of DUBA induced by the co-stimulation of TLR9 and NOD2 inhibited Lys63-linked polyubiquitination of TRAF3 and suppressed TLR9-mediated IFN-alpha production. NOD2 activation in hematopoietic cells protected mice from TLR9-induced exacerbation of DSS-induced colitis by down-regulating IFN-alpha responses and up-regulating DUBA expression. Colonic mucosa of patients with active and remitted IBD phases was characterized by the enhanced and reduced expression of ISGs, respectively. Expression levels of IFN-alpha and IL-6 positively correlated in the active colonic mucosa of patients with ulcerative colitis and CD, whereas DUBA expression inversely correlated with that of IFN-alpha in patients with CD. Collectively, these data suggest that DUBA-dependent negative effect of NOD2 on TLR9-mediated IFN-alpha responses contributes to the maintenance of intestinal homeostasis.
引用
收藏
页码:79 / 94
页数:16
相关论文
共 51 条
[11]   Chronic stimulation of Nod2 mediates tolerance to bacterial products [J].
Hedl, Matija ;
Li, Jing ;
Cho, Judy H. ;
Abraham, Clara .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (49) :19440-19445
[12]   Type I inteferon gene induction by the interferon regulatory factor family of transcription factors [J].
Honda, Kenya ;
Takaoka, Akinori ;
Taniguchi, Tadatsugu .
IMMUNITY, 2006, 25 (03) :349-360
[13]   IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors [J].
Honda, Kenya ;
Taniguchi, Tadatsugu .
NATURE REVIEWS IMMUNOLOGY, 2006, 6 (09) :644-658
[14]   Toll-like receptor 9-induced type IIFN protects mice from experimental colitis [J].
Katakura, K ;
Lee, J ;
Rachmilewitz, D ;
Li, G ;
Eckmann, L ;
Raz, E .
JOURNAL OF CLINICAL INVESTIGATION, 2005, 115 (03) :695-702
[15]   Cell type-specific involvement of RIG-I in antiviral response [J].
Kato, H ;
Sato, S ;
Yoneyama, M ;
Yamamoto, M ;
Uematsu, S ;
Matsui, K ;
Tsujimura, T ;
Takeda, K ;
Fujita, T ;
Takeuchi, O ;
Akira, S .
IMMUNITY, 2005, 23 (01) :19-28
[16]   DUBA: A deubiquitinase that regulates type I interferon production [J].
Kayagaki, Nobuhiko ;
Phung, Qui ;
Chan, Salina ;
Chaudhari, Ruchir ;
Quan, Casey ;
O'Rourke, Karen M. ;
Eby, Michael ;
Pietras, Eric ;
Cheng, Genhong ;
Bazan, J. Fernando ;
Zhang, Zemin ;
Arnott, David ;
Dixit, Vishva M. .
SCIENCE, 2007, 318 (5856) :1628-1632
[17]   Control of IFN-αA by CD73:: Implications for mucosal inflammation [J].
Louis, Nancy A. ;
Robinson, Andreas M. ;
MacManus, Christopher F. ;
Karhausen, Joern ;
Scully, Melanie ;
Colgan, Sean P. .
JOURNAL OF IMMUNOLOGY, 2008, 180 (06) :4246-4255
[18]   An open-labeled, randomized study comparing systemic interferon-α-2A and prednisolone enemas in the treatment of left-sided ulcerative colitis [J].
Madsen, SM ;
Schlichting, P ;
Davidsen, B ;
Nielsen, OH ;
Federspiel, B ;
Riis, P ;
Munkholm, P .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2001, 96 (06) :1807-1815
[19]   Suppression of inflammation in ulcerative colitis by interferon-β-1a is accompanied by inhibition of IL-13 production [J].
Mannon, Peter J. ;
Hornung, Ronald L. ;
Yang, Zhiqiong ;
Yi, Chuli ;
Groden, Catherine ;
Friend, Julia ;
Yao, Michael ;
Strober, Warren ;
Fuss, Ivan J. .
GUT, 2011, 60 (04) :449-455
[20]   Critical role of interferons in gastrointestinal injury repair [J].
McElrath, Constance ;
Espinosa, Vanessa ;
Lin, Jian-Da ;
Peng, Jianya ;
Sridhar, Raghavendra ;
Dutta, Orchi ;
Tseng, Hsiang-Chi ;
Smirnov, Sergey, V ;
Risman, Heidi ;
Sandoval, Marvin J. ;
Davra, Viralkumar ;
Chang, Yun-Juan ;
Pollack, Brian P. ;
Birge, Raymond B. ;
Galan, Mark ;
Rivera, Amariliz ;
Durbin, Joan E. ;
Kotenko, Sergei, V .
NATURE COMMUNICATIONS, 2021, 12 (01)